Short-term vs Conventional Glucocorticoid The...

Medicaid provides health insurance for 1 in 5 Americans and plays a crucial role in US health care infrastructure. The One Big Beautiful Bill Act (OBBBA) is estimated to cut Medicaid spending by nearly $1 trillion by 2034 and cause millions of enrollees to lose coverage. In this ...  Show more

GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, sat down with Jens Juul Holst, MD, DMSc, and Lotte Bjerre Knudsen, DMSc, 2 pioneering scientists behind the discovery and ...  Show more

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK.

In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-day ...

Interview with Jennifer R. Rose-Nussbaumer, MD, author of Steroids and Cross-Linking for Ulcer Treatment: The SCUT II Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Steroids and Cross-Linking for Ulcer Treatment 

Let’s take your breath away… with a review on steroids in treating COPD exacerbations!Time StampsHow does GOLD (Global Initiative for Chronic Obstructive Lung Disease) define a COPD exacerbation? (2:44)What outcomes do steroids actually improve in treating a COPD exacerbation? (5 ...  Show more

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more